Skip to content

TXG

10x Genomics, Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$619M+16.6%
Gross profit$445M+13.1%
Operating income−$72M—
Net income−$67M—
EPS−$0.52—
Free cash flow$94M—